Avicenna.AI
Explore this company’s associated devices, FDA decisions and regulatory history.

Avicenna.AI
- Regulatory records
- 2
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- avicenna.ai
What the linked records show
MedtechLedger currently links 2 FDA records to the applicant name AVICENNA.AI. The collection includes 2 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Oct 19, 2026 to Oct 20, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QBS appears in 1 of the 2 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: Espace Mistral B, 375 Ave. Du Mistral, La Ciotat, 13600, FR. Recorded on K262062, decision dated Oct 20, 2026.
Device categories in this collection
Radiological Computer Assisted Detection/Diagnosis Software For Fracture; Automated Radiological Image Processing Software.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
CINA-AneurysmK262062 | AVICENNA.AI | 510(k) clearance | Oct 20, 2026 | FDA |
CINA-Aneurysm+K262147 | AVICENNA.AI | 510(k) clearance | Oct 19, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.
